[1] [1] THYGESEN K, ALPERT J S, JAFFE A S, et al. Fourth universal definition of myocardial infarction (2018)[J]. Circulation, 2018, 138(20): e618-e651.

[2] [2] ZHANG Q, WANG L, WANG S Q, et al. Signaling pathways and targeted therapy for myocardial infarction[J]. Signal Transduct Target Ther, 2022, 7(1): 78.

[3] [3] ZHU L, LIU Y P, HUANG Y T, et al. Cellular and molecular biology of posttranslational modifications in cardiovascular disease[J]. Biomed Pharmacother, 2024, 179: 117374.

[4] [4] LIU Y P, ZHANG T N, WEN R, et al. Role of posttranslational modifications of proteins in cardiovascular disease[J]. Oxid Med Cell Longev, 2022, 2022: 3137329.

[5] [5] WALKER L A, WALKER J S, KELLY AMBLER S, et al. Stage-specific changes in myofilament protein phosphorylation following myocardial infarction in mice[J]. J Mol Cell Cardiol, 2010, 48(6): 1180-1186.

[6] [6] ZHANG X M, LIU Y L, CAI Y, et al. LRP6-mediated phosphorylation of connexin43 in myocardial infarction[J]. iScience, 2023, 26(3): 106160.

[7] [7] REN J, ZHANG S S, KOVACS A, et al. Role of p38 MAPK in cardiac apoptosis and remodeling after myocardial infarction[J]. J Mol Cell Cardiol, 2005, 38(4): 617-623.

[8] [8] YEH C C, LI H Z, MALHOTRA D, et al. Distinctive ERK and p38 signaling in remote and infarcted myocardium during post-MI remodeling in the mouse[J]. J Cell Biochem, 2010, 109(6): 1185-1191.

[9] [9] MATSUI T, TAO J, DEL MONTE F, et al. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo[J]. Circulation, 2001, 104(3): 330-335.

[10] [10] LI T L, KILIC A, WEI X F, et al. Regional imbalanced activation of the calcineurin/BAD apoptotic pathway and the PI3K/Akt survival pathway after myocardial infarction[J]. Int J Cardiol, 2013, 166(1): 158-165.

[11] [11] ZHANG X D, ZHAO Y, GUO D F, et al. Exercise improves heart function after myocardial infarction: the merits of AMPK[J]. Cardiovasc Drugs Ther, 2024.

[12] [12] YU X, CHEN X, AMRUTE-NAYAK M, et al. MARK4 controls ischaemic heart failure through microtubule detyrosination[J]. Nature, 2021, 594(7864): 560-565.

[13] [13] MISRA A, HAUDEK S B, KNUEFERMANN P, et al. Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction[J]. Circulation, 2003, 108(25): 3075-3078.

[14] [14] KAWANO S, KUBOTA T, MONDEN Y, et al. Blockade of NF-B improves cardiac function and survival after myocardial infarction[J]. Am J Physiol Heart Circ Physiol, 2006, 291(3): H1337-H1344.

[15] [15] MAIER H J, SCHIPS T G, WIETELMANN A, et al. Cardiomyocyte-specific IB kinase (IKK)/NF-B activation induces reversible inflammatory cardiomyopathy and heart failure[J]. Proc Natl Acad Sci USA, 2012, 109(29): 11794-11799.

[16] [16] HAO J, JU H, ZHAO S, et al. Elevation of expression of Smads 2, 3, and 4, decorin and TGF-beta in the chronic phase of myocardial infarct scar healing[J]. J Mol Cell Cardiol, 1999, 31(3): 667-678.

[17] [17] HUMERES C, VENUGOPAL H, FRANGOGIANNIS N G. Smad-dependent pathways in the infarcted and failing heart[J]. Curr Opin Pharmacol, 2022, 64: 102207.

[18] [18] FAN Y, CHENG Y W, LI Y F, et al. Phosphoproteomic analysis of neonatal regenerative myocardium revealed important roles of checkpoint kinase 1 via activating mammalian target of rapamycin C1/ribosomal protein S6 kinase b-1 pathway[J]. Circulation, 2020, 141(19): 1554-1569.

[19] [19] LV F X, WANG Y F, SHAN D, et al. Blocking MG53S255 phosphorylation protects diabetic heart from ischemic injury[J]. Circ Res, 2022, 131(12): 962-976.

[20] [20] YI Z C, KE J Y, WANG Y G, et al. Fluvastatin protects myocardial cells in mice with acute myocardial infarction through inhibiting RhoA/ROCK pathway[J]. Exp Ther Med, 2020, 19(3): 2095-2102.

[21] [21] YU B, SLADOJEVIC N, BLAIR J E, et al. Targeting Rho-associated coiled-coil forming protein kinase (ROCK) in cardiovascular fibrosis and stiffening[J]. Expert Opin Ther Targets, 2020, 24(1): 47-62.

[22] [22] HU S Y, GAO Y, GAO R F, et al. The selective STING inhibitor H-151 preserves myocardial function and ameliorates cardiac fibrosis in murine myocardial infarction[J]. Int Immunopharmacol, 2022, 107: 108658.

[23] [23] FANG Z Y, ZHAO G, ZHAO S, et al. GTF2H4 regulates partial EndMT via NF-B activation through NCOA3 phosphorylation in ischemic diseases[J]. Innovation (Camb), 2024, 5(2): 100565.

[24] [24] HUBBARD M J, COHEN P. On target with a new mechanism for the regulation of protein phosphorylation[J]. Trends Biochem Sci, 1993, 18(5): 172-177.

[25] [25] WATANABE N, OSADA H. Small molecules that target phosphorylation dependent protein-protein interaction[J]. Bioorg Med Chem, 2016, 24(15): 3246-3254.

[26] [26] LEBEK S, CARAVIA X M, CHEMELLO F, et al. Elimination of CaMKⅡ autophosphorylation by CRISPR-Cas9 base editing improves survival and cardiac function in heart failure in mice[J]. Circulation, 2023, 148(19): 1490-1504.

[27] [27] FANG D X, HAWKE D, ZHENG Y H, et al. Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity[J]. J Biol Chem, 2007, 282(15): 11221-11229.

[28] [28] YI X P, WANG X J, GERDES A M, et al. Subcellular redistribution of focal adhesion kinase and its related nonkinase in hypertrophic myocardium[J]. Hypertension, 2003, 41(6): 1317-1323.

[29] [29] CHU M, IYENGAR R, KOSHMAN Y E, et al. Serine-910 phosphorylation of focal adhesion kinase is critical for sarcomere reorganization in cardiomyocyte hypertrophy[J]. Cardiovasc Res, 2011, 92(3): 409-419.

[30] [30] PARK O K, SCHAEFER T S, NATHANS D. In vitro activation of Stat3 by epidermal growth factor receptor kinase[J]. Proc Natl Acad Sci USA, 1996, 93(24): 13704-13708.